Biocardia Historical Financial Ratios

BCDA Stock  USD 2.27  0.06  2.58%   
Biocardia is presently reporting on over 99 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.27, Days Sales Outstanding of 45.8 or Invested Capital of 0.0 will help investors to properly organize and evaluate Biocardia financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocardia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.

About Biocardia Financial Ratios Analysis

BiocardiaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Biocardia investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Biocardia financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Biocardia history.

Biocardia Financial Ratios Chart

At present, Biocardia's Stock Based Compensation To Revenue is projected to slightly grow based on the last few years of reporting. The current year's ROIC is expected to grow to 9.63, whereas Price To Sales Ratio is forecasted to decline to 28.01.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Biocardia stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biocardia sales, a figure that is much harder to manipulate than other Biocardia multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Biocardia dividend as a percentage of Biocardia stock price. Biocardia dividend yield is a measure of Biocardia stock productivity, which can be interpreted as interest rate earned on an Biocardia investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.
Most ratios from Biocardia's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Biocardia current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocardia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.At present, Biocardia's Stock Based Compensation To Revenue is projected to slightly grow based on the last few years of reporting. The current year's ROIC is expected to grow to 9.63, whereas Price To Sales Ratio is forecasted to decline to 28.01.
 2023 2024 (projected)
Dividend Yield0.30.27
Price To Sales Ratio29.4828.01

Biocardia fundamentals Correlations

0.11-1.0-0.07-0.230.150.11.00.46-1.00.970.1-0.210.07-0.050.05-0.02-0.15-0.07-0.231.00.14-0.110.581.0-0.03
0.11-0.10.150.290.19-0.130.10.42-0.10.07-0.14-0.890.550.08-0.1-0.59-0.760.120.290.10.33-0.820.230.10.11
-1.0-0.10.110.21-0.16-0.12-1.0-0.461.0-0.97-0.120.2-0.060.05-0.090.00.130.080.21-1.0-0.170.1-0.61-1.00.07
-0.070.150.110.11-0.64-0.63-0.11-0.340.11-0.24-0.63-0.040.120.64-0.7-0.24-0.20.670.1-0.11-0.46-0.15-0.3-0.110.7
-0.230.290.210.11-0.13-0.23-0.21-0.120.21-0.33-0.24-0.010.270.440.19-0.34-0.390.381.0-0.210.49-0.290.48-0.21-0.2
0.150.19-0.16-0.64-0.130.880.160.46-0.160.360.88-0.260.07-0.9-0.01-0.08-0.14-0.91-0.120.160.07-0.190.450.160.02
0.1-0.13-0.12-0.63-0.230.880.130.27-0.120.321.00.03-0.15-0.85-0.050.170.18-0.94-0.220.13-0.170.130.410.120.05
1.00.1-1.0-0.11-0.210.160.130.45-1.00.970.12-0.20.05-0.050.090.0-0.13-0.08-0.211.00.17-0.10.611.0-0.08
0.460.42-0.46-0.34-0.120.460.270.45-0.460.510.24-0.470.22-0.280.2-0.28-0.42-0.25-0.110.460.34-0.420.430.46-0.19
-1.0-0.11.00.110.21-0.16-0.12-1.0-0.46-0.97-0.120.2-0.060.05-0.090.00.130.080.21-1.0-0.170.1-0.61-1.00.07
0.970.07-0.97-0.24-0.330.360.320.970.51-0.970.32-0.210.03-0.280.060.02-0.1-0.3-0.330.970.11-0.070.590.97-0.04
0.1-0.14-0.12-0.63-0.240.881.00.120.24-0.120.320.03-0.15-0.87-0.060.170.18-0.95-0.230.12-0.180.140.390.120.06
-0.21-0.890.2-0.04-0.01-0.260.03-0.2-0.470.2-0.210.03-0.640.070.060.480.690.03-0.01-0.2-0.320.87-0.15-0.2-0.07
0.070.55-0.060.120.270.07-0.150.050.22-0.060.03-0.15-0.640.06-0.05-0.68-0.710.110.270.060.47-0.560.180.060.07
-0.050.080.050.640.44-0.9-0.85-0.05-0.280.05-0.28-0.870.070.060.07-0.09-0.110.980.43-0.050.15-0.08-0.13-0.05-0.07
0.05-0.1-0.09-0.70.19-0.01-0.050.090.2-0.090.06-0.060.06-0.050.070.190.130.060.190.090.780.10.180.09-1.0
-0.02-0.590.0-0.24-0.34-0.080.170.0-0.280.00.020.170.48-0.68-0.090.190.93-0.14-0.340.0-0.320.49-0.180.0-0.2
-0.15-0.760.13-0.2-0.39-0.140.18-0.13-0.420.13-0.10.180.69-0.71-0.110.130.93-0.15-0.39-0.13-0.420.76-0.31-0.13-0.14
-0.070.120.080.670.38-0.91-0.94-0.08-0.250.08-0.3-0.950.030.110.980.06-0.14-0.150.37-0.080.17-0.11-0.24-0.08-0.06
-0.230.290.210.11.0-0.12-0.22-0.21-0.110.21-0.33-0.23-0.010.270.430.19-0.34-0.390.37-0.210.49-0.290.48-0.21-0.2
1.00.1-1.0-0.11-0.210.160.131.00.46-1.00.970.12-0.20.06-0.050.090.0-0.13-0.08-0.210.17-0.10.611.0-0.07
0.140.33-0.17-0.460.490.07-0.170.170.34-0.170.11-0.18-0.320.470.150.78-0.32-0.420.170.490.17-0.340.410.17-0.78
-0.11-0.820.1-0.15-0.29-0.190.13-0.1-0.420.1-0.070.140.87-0.56-0.080.10.490.76-0.11-0.29-0.1-0.34-0.23-0.1-0.11
0.580.23-0.61-0.30.480.450.410.610.43-0.610.590.39-0.150.18-0.130.18-0.18-0.31-0.240.480.610.41-0.230.61-0.17
1.00.1-1.0-0.11-0.210.160.121.00.46-1.00.970.12-0.20.06-0.050.090.0-0.13-0.08-0.211.00.17-0.10.61-0.07
-0.030.110.070.7-0.20.020.05-0.08-0.190.07-0.040.06-0.070.07-0.07-1.0-0.2-0.14-0.06-0.2-0.07-0.78-0.11-0.17-0.07
Click cells to compare fundamentals

Biocardia Account Relationship Matchups

Biocardia fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio29.26241.4532.3427.3929.4828.01
Ptb Ratio8.761.833.167.57(8.77)(9.21)
Days Sales Outstanding75.572.1K52.8654.2648.2145.8
Book Value Per Share6.328.439.24.14(1.14)(1.08)
Free Cash Flow Yield(0.46)(0.35)(0.32)(0.29)(0.71)(0.75)
Operating Cash Flow Per Share(25.1)(18.32)(9.19)(8.94)(7.06)(7.42)
Stock Based Compensation To Revenue4.443.8320.360.882.162.4
Capex To Depreciation0.751.320.471.930.850.14
Pb Ratio8.761.833.167.57(8.77)(9.21)
Ev To Sales23.098.0521.4923.1529.9328.43
Free Cash Flow Per Share(25.49)(18.37)(9.29)(9.0)(7.07)(7.43)
Roic(4.94)(0.78)(1.19)(2.29)9.179.63
Inventory Turnover3.6789.5(0.004706)(59.21)(68.09)(64.69)
Net Income Per Share(39.38)(22.24)(11.19)(10.08)(8.19)(8.6)
Days Of Inventory On Hand4.08(77.6K)5.7E-4(6.16)(7.09)(7.44)
Payables Turnover0.390.0053621.2617.428.6813.27
Research And Ddevelopement To Revenue12.0667.658.436.5316.211.51
Capex To Revenue0.110.210.220.05180.02520.0239
Cash Per Share14.8431.7311.416.230.780.74
Pocfratio(2.2)(2.83)(3.17)(3.51)(1.41)(1.34)
Capex To Operating Cash Flow(0.0155)(0.00259)(0.0112)(0.006628)(0.001203)(0.001263)
Pfcf Ratio(2.17)(2.83)(3.13)(3.48)(1.41)(1.34)
Days Payables Outstanding931.8768.1K289.1520.9542.0539.94
Income Quality0.790.640.820.890.861.08
Roe(6.25)(0.78)(1.22)(2.44)7.227.58
Ev To Operating Cash Flow(1.73)(1.15)(2.1)(2.96)(1.43)(1.36)
Pe Ratio(1.4)(2.33)(2.6)(3.11)(1.22)(1.15)
Return On Tangible Assets(1.93)(0.64)(0.8)(1.22)(3.87)(3.68)
Ev To Free Cash Flow(1.7)(1.15)(2.08)(2.94)(1.43)(1.36)
Earnings Yield(0.71)(0.43)(0.38)(0.32)(0.82)(0.78)
Net Debt To E B I T D A0.321.440.880.48(0.0183)(0.0193)
Current Ratio1.595.333.632.190.40.38
Tangible Book Value Per Share6.328.439.24.14(1.14)(1.08)
Receivables Turnover4.830.176.96.737.577.67
Graham Number74.71119.2848.1330.6514.4713.74
Shareholders Equity Per Share6.328.439.24.14(1.14)(1.08)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biocardia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biocardia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardia Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocardia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Revenue Per Share
0.264
Quarterly Revenue Growth
(0.93)
Return On Assets
(1.16)
Return On Equity
(7.04)
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biocardia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.